Meyer Philipp T, Sattler Bernhard, Lincke Thomas, Seese Anita, Sabri Osama
Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
J Nucl Med. 2003 May;44(5):839-45.
With (123)I-labeled N-omega-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl)nortropane (FP-CIT) SPECT increasingly gaining access into routine patient care, the comparability of the results of different SPECT systems in the quantification of receptor binding is important for accurate clinical decision making and the translation of imaging results between institutions (e.g., as part of multicenter therapy trials).
In a series of studies using phantoms (containing target cylinders of 2- and 2.8-cm diameter) and (123)I-FP-CIT patient studies (n = 49), we compared target-to-background (T/BG) and (123)I-FP-CIT striatal uptake ratios recovered by a conventional triple-head SPECT system and a dedicated high-resolution brain SPECT system. All patient studies were acquired on both SPECT systems successively (<15-min interscan gap) using a single-injection protocol (group A [n = 20] was first scanned on the triple-head SPECT system, and group B [n = 29] was first scanned on the dedicated brain SPECT system).
In phantom studies, the T/BG ratios recovered by both systems correlated strongly with the true T/BG ratios (R(2) > 0.96), with the linear regression slopes being 0.86-1.17 and 0.41-0.52 (less steep for smaller target size and lower T/BG ratios) for the dedicated brain SPECT and the triple-head SPECT system, respectively. Although both systems yielded markedly different results, they showed a high linear correlation with each other (R(2) > 0.95, no significant effect from target size). In (123)I-FP-CIT patient studies, a similar linear intersystem correlation was found (R(2) [A/B] = 0.79/0.80, 0.52/0.68, and 0.83/0.85 for the uptake ratios of the striatum, caudate, and putamen, respectively, to the occipital reference region).
A linear transformation of striatal uptake ratios between different SPECT systems appears to be achievable for ligands such as (123)I-FP-CIT. An evaluation is needed of whether the present method can do this with sufficient accuracy for clinical purposes or whether methodologic adaptations are necessary. Proper study timing has to be ensured.
随着(123)I标记的N-ω-氟丙基-2-β-甲氧基羰基-3-β-(4-碘苯基)去甲托烷(FP-CIT)单光子发射计算机断层扫描(SPECT)越来越多地应用于常规患者护理,不同SPECT系统在受体结合定量方面结果的可比性对于准确的临床决策以及机构间成像结果的转换(例如,作为多中心治疗试验的一部分)非常重要。
在一系列使用体模(包含直径为2厘米和2.8厘米的靶圆柱体)和(123)I-FP-CIT患者研究(n = 49)的研究中,我们比较了传统三头SPECT系统和专用高分辨率脑SPECT系统获得的靶本底(T/BG)和(123)I-FP-CIT纹状体摄取率。所有患者研究均使用单注射方案在两个SPECT系统上相继进行(扫描间隔<15分钟)(A组[n = 20]先在三头SPECT系统上扫描,B组[n = 29]先在专用脑SPECT系统上扫描)。
在体模研究中,两个系统获得的T/BG比率与真实T/BG比率高度相关(R²>0.96),专用脑SPECT系统和三头SPECT系统的线性回归斜率分别为0.86 - 1.17和0.41 - 0.52(对于较小的靶尺寸和较低的T/BG比率斜率较平缓)。虽然两个系统得出的结果明显不同,但它们相互之间显示出高度线性相关性(R²>0.95,不受靶尺寸的显著影响)。在(123)I-FP-CIT患者研究中,发现了类似的系统间线性相关性(纹状体、尾状核和壳核与枕叶参考区域的摄取率的R²[A/B]分别为0.79/0.80、0.52/0.68和0.83/0.85)。
对于(123)I-FP-CIT等配体,不同SPECT系统之间纹状体摄取率的线性转换似乎是可行的。需要评估当前方法是否能在临床上以足够的准确性做到这一点,或者是否需要进行方法学调整。必须确保合适的研究时机。